GlobeNewswire Inc.··NaBioRestorative Completes Phase 2 Dosing for BRTX-100, Eyes 2027 Spine Data
BioRestorative finishes Phase 2 dosing of BRTX-100 for chronic lumbar disc disease across 99 patients, with topline data expected in Q2 2027.
BRTXPhase 2 clinical trialregenerative medicine